Metformin, a well‐tolerated antidiabetic drug, was able to reduce the expression of toxic repetitive proteins produced from the C9orf72 repeat expansion by interfering with a key pathway and to mitigate disease features in a C9orf72‐ALS/FTD mouse model (Rosbash 2020). This evidence concerns the gene C9orf72 and frontotemporal dementia.